Drug Profile
Doxycycline controlled release - Promius Pharma
Alternative Names: DFD 09; Doxycycline modified release - Promius Pharma; Modified release oral tetracycline - Promius Pharma; ZenavodLatest Information Update: 17 Sep 2021
Price :
$50
*
At a glance
- Originator Promius Pharma
- Class Antibacterials; Antimalarials; Antineoplastics; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Rosacea
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Rosacea in Austria (PO)
- 21 Apr 2018 Pharmacokinetics data from a clinical trial in Healthy volunteers presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 30 Nov 2017 Doxycycline controlled release is still tentatively approved in the US